Purchase Order 36C26123P0479

United Therapeutics Corporation has been awarded a $14,221.32 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order is for the drug TYVASO (NDC: 66302-0206-02) and has a completion date of May 26, 2023. Performance will take place in Silver Spring, Maryland. No set-aside designation was applied to this order issued under Master GSA...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA-VHA) awarded a $298,647.72 delivery order contract to United Therapeutics Corporation under the Pharmaceuticals and Drugs (FSS-61-IB) master GSA schedule. The contract description references TYVASO, which is a proprietary treprostinil inhalation solution used to treat pulmonary arterial hypertension. United Therapeutics will provide TYVASO to the VA-VHA from its place of performance in...

This is a $16,031.60 firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for the drug TYVASO 64 MCG KIT, which is used to treat pulmonary arterial hypertension. The delivery order was placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. United Therapeutics also holds two...

This is a $75,656.34 firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The order is for a 6-month supply of Tyvaso (treprostinil) 0.6mg/mL inhalation solution refill kits. This delivery order is placed against United Therapeutics' $50 million Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for the supply of its...

The Department of Veterans Affairs Veterans Health Administration awarded a $85,327.92 firm fixed price delivery order against the United Therapeutics Corporation's Pharmaceuticals and Drugs schedule (FSS-61-IB) to provide TYVASO for Veterans Integrated Service Network 20. Performance will take place in Silver Spring, Maryland over a six-month period concluding on March 31, 2024. No subcontractors or set aside designations were specified. This order supports the VA's mission to provide quality...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $42,663.96 firm fixed price delivery order to United Therapeutics Corporation under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for TYVASO 0.6MG/ML REFILL KITS to be delivered to a location in North Las Vegas, Nevada, with performance spanning from September 6, 2023 to January 31, 2024. As the leading provider of pulmonary arterial hypertension...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $14,693.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to United Therapeutics Corporation for one kit of treprostinil (Tyvaso) 0.6mg/ml solution for inhalation, refill. Performance will occur in Silver Spring, Maryland by March 8, 2024. The contract utilizes the GSA Schedule for pharmaceuticals and drugs with firm fixed pricing and no...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded United Therapeutics Corporation a $14,221.32 firm fixed price delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for X2 EMERGENCY TYVASO 0.6MG/ML REFILLS to be delivered to Silver Spring, Maryland between June 30 and July 30, 2023. As the leading provider of pulmonary arterial hypertension treatment, United Therapeutics will supply the...

United Therapeutics Corporation has been awarded a $15,649.11 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of TYVASO 64 MCG ORAL INH KIT to Bartlett, Tennessee, with performance required by March 16, 2023. No set-aside designation was applied to this order placed under GSA Schedule FSS-61-IB for the purpose of...

United Therapeutics Corporation has been awarded a $109,543.77 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The firm fixed price order has a completion date of September 30, 2023 and was awarded on March 21, 2023 to provide TYVASO, with no set-aside designation used. Place of performance will be in Bartlett, Tennessee. TYVASO will support the VA's mission...